YOUR BUSINESS AUTHORITY
Springfield, MO
Reckitt Benckiser Group Plc has ended talks to potentially buy a portion of Pfizer Inc.'s consumer health division.
According to Bloomberg, the division is valued at $15 billion to $20 billion.
Reckitt CEO Rakesh Kapoor reportedly was mostly interested in Pfizer's U.S. Advil business but not everything else in the unit.
Read more from Bloomberg.
Project work in Springfield corridor will continue into 2031.